SCHEMBL14459963

SCHEMBL14459963

c1ccc(-c2nc3cc(-c4ccc5c(-c6ccccc6)c6ccccc6c(-c6ccccc6)c5c4)ccc3[nH]2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 5/20 0.53
▸ RAB9A P51151 5/20 0.53
▸ GAA P10253 3/20 0.53
▸ PDE10A Q9Y233 1/20 0.46
▸ HPGD P15428 6/20 0.46
▸ KDM4E B2RXH2 6/20 0.46
▸ ALDH1A1 P00352 6/20 0.46
▸ SMN1; SMN2 Q16637 5/20 0.46
▸ MAPT P10636 3/20 0.46
▸ TP53 P04637 3/20 0.46
▸ HSD17B10 Q99714 3/20 0.46
▸ GFER P55789 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ GLA P06280 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ RCE1 Q9Y256 1/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ FTO Q9C0B1 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14459921 0.99 NPC1 (0.51) NPC1RAB9AGAAPDE10AHPGD
SCHEMBL14459692 0.99 NPC1 (0.54) NPC1RAB9AGAAPDE10AHPGD
SCHEMBL14459924 0.97 NPC1 (0.53) NPC1RAB9AGAAPDE10AHPGD
SCHEMBL24063115 0.85 NPC1 (0.60) NPC1RAB9AGAAPDE10AHPGD
SCHEMBL22649095 0.85 NPC1 (0.67) NPC1RAB9AGAAHPGDKDM4E
SCHEMBL16002467 0.84 NPC1 (0.51) NPC1RAB9AGAAPDE10AHPGD
SCHEMBL21769798 0.84 NPC1 (0.48) NPC1RAB9AGAAPDE10AHPGD
SCHEMBL17755354 0.83 NPC1 (0.55) NPC1RAB9AGAAPDE10AHPGD
SCHEMBL16281922 0.80 NPC1 (0.66) NPC1RAB9AGAAPDE10AHPGD
SCHEMBL16000738 0.80 NPC1 (0.70) NPC1RAB9AGAAHPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070200490-A1 Nitrogenous Heterocycle Derivative, And Organic Electroluminescent Element Employing The Same IDEMITSU KASON CO.LTD (JP) 2007-08-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070200490-A1 Nitrogenous Heterocycle Derivative, And Organic Electroluminescent Element Employing The Same RPS3A, NCOA3, HNRNPA0 NPC1 4031/4885RAB9A 779/4885GAA 4188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback